Innovative AI Tool Enhances Heart Disease Detection Using Standard ECG Data
A cutting-edge AI tool analyzes routine ECG data to detect hidden structural heart diseases, promising earlier diagnosis and treatment opportunities. Developed by Columbia University researchers, EchoNext offers a cost-effective, non-invasive method to identify patients needing further cardiac evaluation, potentially saving countless lives.
Recent advancements in artificial intelligence (AI) have led to the development of a novel, cost-effective screening tool capable of identifying hidden structural heart diseases from routine electrocardiogram (ECG) data. Traditionally, ECGs are employed to detect abnormal heart rhythms, blockages, and previous heart attacks, but they have limitations in diagnosing structural issues such as valve disease and cardiomyopathy. To bridge this gap, researchers at Columbia University Irving Medical Center and NewYork-Presbyterian created EchoNext, an AI-powered system that analyzes standard ECG readings to determine which patients should proceed with an echocardiogram—a more detailed, ultrasound-based heart imaging test.
The AI model was trained on over 1.2 million paired ECG and echocardiogram data from 230,000 patients, enabling it to spot signs of structural heart problems more accurately than many cardiologists, even with AI assistance. In a validation study across four hospital systems, including several NewYork-Presbyterian campuses, EchoNext demonstrated high accuracy in detecting conditions like heart failure, valve disease, pulmonary hypertension, and significant heart thickening. When compared directly with 13 cardiologists analyzing 3,200 ECGs, EchoNext correctly identified 77% of structural heart diseases, outperforming human experts with a 64% accuracy rate.
In real-world applications, the AI system screened nearly 85,000 patients who had not previously undergone echocardiography. It flagged over 7,500 individuals as high-risk, and during follow-up, about 55% of these patients subsequently received their first echocardiogram, leading to a diagnosis of structural heart disease in nearly three-quarters of them. This approach has the potential to significantly increase early detection, potentially saving many lives by enabling timely treatment. The team has also shared anonymized data to support further research and is conducting clinical trials to implement EchoNext in emergency settings. Overall, this innovation exemplifies how AI can transform cardiac screening, making it more accessible and effective worldwide.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Approach Targets Mitochondrial Dysfunction to Protect Children’s Vision
New research identifies a groundbreaking approach to prevent vision loss in children with ADOA by targeting mitochondrial dysfunction and the SARM1 protein, offering hope for future therapies.
Mpox Outbreak in Sierra Leone: Causes, Risks, and Preventive Measures
Sierra Leone faces a rising mpox outbreak with over 4,000 cases, driven by person-to-person transmission. Regional risks are growing, urging enhanced surveillance, vaccination, and regional cooperation to prevent wider spread.
Women's Age at First Menstruation as a Predictor of Long-Term Health Risks
Research shows that the age at which women have their first period can predict long-term health risks, including obesity, heart disease, and reproductive issues, guiding personalized prevention strategies.
Parents' Delayed Decisions on Discontinuing Pacifiers and Thumb-Sucking in Children Revealed by New Poll
A new survey reveals that many parents delay ending pacifier use and thumb-sucking in children, risking long-term dental and speech issues. Early intervention strategies and patience are key.